Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
University Of California Riverside has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, JESSICA NICOLE STOCKDALE. The portfolio is active within 1 distinct art unit.
JESSICA NICOLE STOCKDALE is the busiest examiner, holding 1 pending office action. As the university only has 1 pending office action in total, this examiner is responsible for the entire active portfolio. This allows for a highly focused prosecution effort within the Biotechnology & Pharmaceuticals sector. The alignment of 1 pending office action with 1 distinct examiner and 1 distinct art unit simplifies the prosecution landscape.
Practitioners can focus on the specific requirements and tendencies of JESSICA NICOLE STOCKDALE. This singular focus is characteristic of portfolios with a single active matter. By concentrating resources on one examiner and one art unit, the university can develop a deep understanding of the specific standards applied to their Biotechnology & Pharmaceuticals applications. This structure minimizes the administrative burden of tracking different examiner behaviors.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOCKDALE, JESSICA NICOLE | 1 | 51.4% | +33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18644446 | DEVELOPMENT OF SPECIFICALLY TARGETED BINDERS AND ANTIMICROBIAL PEPTIDES (STAMPs) TO CONTROL CANDIDATUS LIBERIBACTER SPP. | STOCKDALE, JESSICA NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18644446 | DEVELOPMENT OF SPECIFICALLY TARGETED BINDERS AND ANTIMICROBIAL PEPTIDES (STAMPs) TO CONTROL CANDIDATUS LIBERIBACTER SPP. | STOCKDALE, JESSICA NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18644446 | DEVELOPMENT OF SPECIFICALLY TARGETED BINDERS AND ANTIMICROBIAL PEPTIDES (STAMPs) TO CONTROL CANDIDATUS LIBERIBACTER SPP. | STOCKDALE, JESSICA NICOLE | 1663 | §101§102§103§112 | Final Rejection | — | Pending | Apr 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity Of California Riverside has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jessica Nicole Stockdale has the most, with 1 of University Of California Riverside's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
